Mohan, ArjunHarrison, TimChanez, PascalMenzella, FrancescoCanonica, Giorgio WalterLouis, RenaudCosio, BorjaLugogo, NjiraBurden, AnnieMcdermott, Lawrence2022-10-142022-10-142021http://hdl.handle.net/10342/11522en-USeosinophilic asthmabenralizumablung functionOnset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b TrialArticle